Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+202.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
27.6x
Strong expansion
Streak
6 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.26 | +89.0% |
| 2024 | 0.14 | +92.5% |
| 2023 | 0.07 | +659.9% |
| 2022 | 0.01 | +54.0% |
| 2021 | 0.01 | - |
| 2020 | 0.00 | +100.0% |
| 2019 | -0.01 | - |
| 2018 | 0.00 | - |